Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm.
Maria FilìEric TrocmeLouise BergmanThonnie Rose Ong SeeHelder AndréKatarina BartumaLeonard GirnitaCharlotta All-ErikssonStefan SeregardGustav StålhammarPublished in: The British journal of ophthalmology (2019)
Rates of repeated brachytherapy were significantly higher among patients treated with 106Ru versus 125I for thick choroidal melanomas. There were, however, no significant differences in rates of enucleation or patient survival.